期刊文献+

宫颈锥切术后切缘阳性相关因素及处理分析 被引量:4

Analysis of risk factors and management of positive margin after cervix conization
原文传递
导出
摘要 目的回顾性分析宫颈锥切术后切缘阳性患者的病例特点及诊疗经过,为其后续诊治提供依据。方法收集2017年1月~2019年6月因宫颈病变于潍坊市人民医院住院行宫颈锥切术者606例(术后病理示切缘阳性者107例),分析所有患者年龄、孕产史、是否绝经等临床因素及切缘阳性患者的补充治疗情况。结果①首次宫颈锥切术后病理提示切缘阳性者占总锥切手术患者的17.7%;切缘阳性补充治疗者占20.6%,补充治疗术后病理有病灶残留者占59.1%.②单因素分析结果显示,宫颈锥切术后切缘阳性与术前宫颈HPV感染情况、宫颈活检病理级别因素有关(χ^2=12.806,P<0.05;χ^2=33.691;P<0.05)。③多因素Logistic回归分析结果显示,宫颈HPV16,18型感染和活检病理提示浸润癌这两个因素是宫颈锥切术后切缘阳性的危险因素,其OR值分别为2.006(95%CI为1.206-3.337)、22.446(95%CI为2.834-177.775)。结论宫颈锥切术后切缘阳性患者需个体化治疗,其中HPV16,18型感染和活检病理提示浸润癌为高危因素,需根据患者自身情况建议补充手术治疗。 Objective Retrospectively analyze the case characteristics and diagnosis and treatment of patients with positive margins after cervical conization,to provide a basis for the follow-up diagnosis and treatment of such patients.Methods A total of 606 patients who underwent cervix conization at the Weifang People’s Hospital for cervical lesions from January 2017 to June 2019(107 cases with positive resection margin after pathology)were enrolled.Analyze the clinical factors such as age,maternal history,menopause,etc.of all patients and the complementary treatment of patients with positive margins.Results①The rate of the positive margin in patients with cervix conization was 17.7%.Those who with positive margins of supplementary treatment accounted for 20.6%,and those who with residual pathology after supplementary treatment accounted for 59.1%.②Single factor analysis showed that the positive margin after cervix conization was related to HPV infection and the pathological grade of cervical biopsy before surgery(P<0.05).③The logistic regression analysis showed that cervical HPV16,18 infection and biopsy pathology suggest that invasive cancer was a risk factor associated with the positive margin,with OR values of 2.006(95%CI 1.206 to 3.337)and 22.446(95%CI 2.834 to 177.775).Conclusions Patients with positive margins after cervical conization need individual treatment.Among them,HPV16,18 infection and biopsy pathology suggested that invasive cancer were high-risk factor,and supplementary surgical treatment was recommended according to the patient’s own condition.
作者 王晓诺 张盈盈 王佳森 万修聪 陈芳 WANG Xiaonuo;ZHANG Yingying;WANG Jiasen;WAN Xiucong;CHEN Fang(Department of Obsterics and Gynecology,Weifang Medical University,Weifang 261053,China;Department of Gynecology,Weifang People's Hospital)
出处 《潍坊医学院学报》 2020年第2期134-136,共3页 Acta Academiae Medicinae Weifang
关键词 宫颈上皮内瘤变 宫颈锥切术 切缘阳性 危险因素 病灶残留 Cervical intraepithelial neoplasia Conization Positive margin Risk factor Residual lesions
  • 相关文献

参考文献6

二级参考文献49

  • 1郝敏,王静芳.宫颈癌流行病学研究与调查[J].国外医学(妇幼保健分册),2005,16(6):404-406. 被引量:91
  • 2李隆玉,乔志强,张燕玲.不同病理类型宫颈癌发病年龄趋势的初步观察[J].中国肿瘤临床,2007,34(6):338-340. 被引量:15
  • 3Berkowitz RP. 2012 updated consensus guidelines for the manage- ment of abnormal cervical cancer screening tests and cancer precur- sors[J]. Obstet Gyneco1,2013,122(2 Pt 1 ) :393.
  • 4Zhao C,Austin RM. Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone[J]. Gynecol Oncol, 2007,107 (2) : 231-235.
  • 5Beeby AR,Wadehra V, Keating PJ, et al. A retrospective analysis of 94 patients with CIN and false negative cervical smears taken at colposcopy[J]. Cytopathology, 1993,4(6 ) : 33 i-337.
  • 6Robertson JH,Woodend B. Negative cytology preceding cervical cancer: causes and prevention [J]. J Clin Pathol, 1993,46 (8) : 700- 702.
  • 7Katki HA, Schiffman M, Castle PE, et al. Five-year risks of CIN 3 + and cervical cancer among women who test Pap-negative but are HPV-positivc[J]. J Low Genit Tract Dis, 2013,17 (5 Suppl 1 ) : $56- $63.
  • 8Castle PE, Fetterman B,Poitras N,et al. Five -year experience of human papillomavirus DNA and Papanicolaou test cotesting [J]. Obstct Gynecol, 2009,113 (3) : 595-600.
  • 9Katki HA,Kinney WK,Fetterman B,ct al. Cervical cancer risk forwomen undergoing concurrent testing for human papillomavirus and cervical cytology:a population-based study in routine clinical practice[J]. Lancet Oncol, 2011,12(7 ) : 663-672.
  • 10Katki HA,Schiffman M,Castle PE,et al. Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results[J]. J Low Genit Tract Dis, 2013,17 (5 Suppl 1 ) :36-42.

共引文献666

同被引文献45

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部